Iaso Therapeutics

East Lansing, MI · Founded 2018 · Privately Held (backing)

Operator of synthetic antigen-based vaccines designed to prevent and treat infectious diseases. Iaso Therapeutics is based in East Lansing, MI and was founded in 2018. Its last reported valuation was $5.3 million in Jan 2023. It has raised $1.8 million across 2 recorded rounds; the latest was a $570,000 seed round in Jan 2026.

Last reported valuation
$5.3M
Oct 2026
Priced at
—
Total raised
$1.8M
Last round
Seed Round
Jan 2026

Who backs Iaso Therapeutics?

6 investors
InvestorType
US National Science FoundationOther
Michigan RiseVenture capital
Apjohn Group—
Biosciences Research and Commercialization Center—
National Institute Of Allergy and Infectious Diseases—
Red Cedar Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Iaso Therapeutics investors

6 investors are on record for Iaso Therapeutics, including US National Science Foundation, Michigan Rise, Apjohn Group and Biosciences Research and Commercialization Center. The seed round in Jan 2026 drew 1 investor.

Free account
More of Iaso Therapeutics with a free account
  • ·Watch Iaso Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Iaso Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View